
RobotLAB Expands “AI, Robotics & the Future of Work” Lineup
DALLAS--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:59

Marketmind: Markets buckle under US rates, China blues
By Jamie McGeever A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist.
2023-07-07 05:58

Taylor Swift agreed to $100 million deal with FTX before it went bankrupt, but FTX pulled out
Taylor Swift signed onto a lucrative touring partnership with FTX before its collapse, but FTX pulled out of the arrangement, according to a person familiar with the discussions.
2023-07-07 05:53

Cierto Tequila Awarded Five Double Gold Medals at the 2023 Singapore World Spirits Competition
LOS ANGELES--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:50

Birkenstock Owner Considers IPO at $6 Billion-Plus Value
L Catterton, the private equity firm backed by luxury French fashion house LVMH, is considering strategic options for
2023-07-07 05:46

BOJ Deputy Governor Uchida: Will maintain yield control to sustain easy policy
By Leika Kihara TOKYO Bank of Japan (BOJ) Deputy Governor Shinichi Uchida said the central bank will maintain
2023-07-07 05:45

Railroad industry sues to block limit on crew sizes that Ohio imposed after E. Palestine derailment
The railroad industry has sued to block a new minimum crew-size requirement that Ohio imposed after a fiery train derailment in East Palestine in February
2023-07-07 05:25

AbbVie trims full-year profit forecast on higher R&D expenses
(Reuters) -AbbVie Inc cut its full-year profit forecast on Thursday, citing $280 million in milestone and in-process research and development
2023-07-07 05:20

L Catterton considering IPO for Birkenstock at $6 billion- Bloomberg News
L Catterton, a private equity firm backed by LVMH, is considering strategic options for Birkenstock including an initial
2023-07-07 05:15

Salt-N-Pepa’s Sandra “Pepa” Denton and Entertainer MAJOR. Drum up Excitement for Celebrate St. Jude Brunch
NEW ORLEANS--(BUSINESS WIRE)--Jul 6, 2023--
2023-07-07 05:15

Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it
U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease
2023-07-07 04:59

Nikola pushes shareholder meet again as it seeks nod for key proposal
Electric-truck maker Nikola on Thursday adjourned its annual shareholder meeting for the second time this year, as it
2023-07-07 04:59